Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization

Abstract

Pathologic ocular neovascularization commonly causes blindness. It is critical to identify the factors altered in pathologically proliferating versus normally quiescent vessels to develop effective targeted therapeutics. MicroRNAs regulate both physiological and pathological angiogenesis through modulating expression of gene targets at the posttranscriptional level. However, it is not completely understood if specific microRNAs are altered in pathologic ocular blood vessels, influencing vascular eye diseases. Here we investigated the potential role of a specific microRNA, miR-150, in regulating ocular neovascularization. We found that miR-150 was highly expressed in normal quiescent retinal blood vessels and significantly suppressed in pathologic neovessels in a mouse model of oxygen-induced proliferative retinopathy. MiR-150 substantially decreased endothelial cell function including cell proliferation, migration, and tubular formation and specifically suppressed the expression of multiple angiogenic regulators, CXCR4, DLL4, and FZD4, in endothelial cells. Intravitreal injection of miR-150 mimic significantly decreased pathologic retinal neovascularization in vivo in both wild-type and miR-150 knockout mice. Loss of miR-150 significantly promoted angiogenesis in aortic rings and choroidal explants ex vivo and laser-induced choroidal neovascularization in vivo. In conclusion, miR-150 is specifically enriched in quiescent normal vessels and functions as an endothelium-specific endogenous inhibitor of pathologic ocular neovascularization.neovascularization | endothelial cells | microRNA | miR-150 | retinopathy

Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy

“…Vascular tubular formation was imaged and quantified by measuring branching points and vessel length per view field as described previously. 35 …”

Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis

“…Neovascularization can be suppressed with anti-angiogenic agents, such as anti-vascular endothelial growth factor (VEGF) molecules (Cheung et al, 2012, Liu et al, 2015). However, anti-VEGF therapy can also suppress normal vessel growth and neuronal survival (Suzuki et al, 2011, Sato et al, 2012).…”

Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization

“…Pathological retinal and choroidal neovascularization can be suppressed temporarily with anti-angiogenic agents. In particular, anti-vascular endothelial growth factor (VEGF) molecules have been used successfully for the treatment of neovascular AMD, DR and ROP, but with some adverse effects 4, 5 . Suppressing VEGF signaling does not address the underlying causes of neovascularization.…”